Brianti Emanuele, Napoli Ettore, Gaglio Gabriella, Falsone Luigi, Giannetto Salvatore, Solari Basano Fabrizio, Nazzari Roberto, Latrofa Maria Stefania, Annoscia Giada, Tarallo Viviana Domenica, Stanneck Dorothee, Dantas-Torres Filipe, Otranto Domenico
Dipartimento di Scienze Veterinarie, Università degli Studi di Messina, Messina, Italy.
Arcoblu s.r.l., Milano, Italy.
PLoS Negl Trop Dis. 2016 Sep 15;10(9):e0004987. doi: 10.1371/journal.pntd.0004987. eCollection 2016 Sep.
This study investigated the efficacy of two collars for the treatment and prevention of flea infestations. Additionally the effect of these collars on the incidence of Leishmania infantum infection as compared with a group of vaccinated dogs was evaluated. A total of 224 young dogs from private animal shelters were enrolled in April/May into four groups: G1, 55 dogs treated with 10% imidacloprid + 4.5% flumethrin collar (Seresto, Bayer Animal Health); G2, 60 dogs treated with 4% deltamethrin collar (Scalibor protector band, MSD Animal Health); G3, 54 dogs vaccinated with CaniLeish (Virbac Animal Health); and G4, 55 dogs left non-treated as controls. Dogs were followed up at days 120 (September), 210 (December), and 360 (April-May). At those time points, clinical assessments, ectoparasite counts and blood, bone marrow and skin samples, to detect the presence of L. infantum, were performed. The efficacy of Seresto in protecting dogs from flea infestation was 100% (P < 0.01) on day 120 and 210, while animals treated with Scalibor showed a prevalence of the infestation ranging from 23.3% to 33.3% on day 120 and 210, respectively. At the end of the study, the incidence of L. infantum infection in collared dogs-based on animals being positive in any of the tests-was 5.5% in Seresto-treated dogs and 20% in Scalibor-treated dogs, resulting in overall efficacy of prevention of 88.3% for Seresto and 61.8% for Scalibor. No statistical difference was detected in L. infantum positive dogs for bone marrow PCR and/or cytology at day 360 between the CaniLeish (15.4%) and non-treated control dogs (10.0%). Both collars proved to be effective (P < 0.01) in preventing L. infantum infection throughout one transmission season, whereas no significant difference was recorded in the frequency of active infections between dogs vaccinated with CaniLeish and control dogs, emphasizing the importance of using repellent/insecticide actives as a priority measure for protection against canine leishmaniosis.
本研究调查了两种项圈在治疗和预防跳蚤感染方面的效果。此外,还评估了与一组接种疫苗的犬只相比,这些项圈对婴儿利什曼原虫感染发生率的影响。4月/5月,共有224只来自私人动物收容所的幼犬被纳入四组:G1组,55只犬佩戴含10%吡虫啉+4.5%氟氯氰菊酯的项圈(Seresto,拜耳动物保健公司)进行治疗;G2组,60只犬佩戴含4%溴氰菊酯的项圈(Scalibor防护带,默克动物保健公司)进行治疗;G3组,54只犬接种CaniLeish疫苗(维克动物保健公司);G4组,55只犬不进行任何处理作为对照。在第120天(9月)、第210天(12月)和第360天(4月 - 5月)对犬只进行随访。在这些时间点,进行临床评估、体外寄生虫计数,并采集血液、骨髓和皮肤样本以检测婴儿利什曼原虫的存在。Seresto在第120天和第210天保护犬只免受跳蚤感染的效果为100%(P < 0.01),而佩戴Scalibor项圈的动物在第120天和第210天的跳蚤感染率分别为23.3%至33.3%。在研究结束时,基于任何一项检测呈阳性的动物,佩戴项圈的犬只中婴儿利什曼原虫感染的发生率在Seresto治疗组为5.5%,在Scalibor治疗组为20%,Seresto预防的总体效果为88.3%,Scalibor为61.8%。在第360天,CaniLeish疫苗接种组(15.4%)和未处理的对照组犬只(10.0%)之间,在婴儿利什曼原虫阳性犬只的骨髓PCR和/或细胞学检查方面未检测到统计学差异。两种项圈在整个一个传播季节预防婴儿利什曼原虫感染方面均被证明是有效的(P < 0.01),而接种CaniLeish疫苗的犬只和对照犬只之间在活动性感染频率方面未记录到显著差异,这强调了使用驱避剂/杀虫剂作为预防犬利什曼病的优先措施的重要性。